Multipotent capacity of morphologically intermediate (I-type) human neuroblastoma cells after treatment with differentiation-inducing drugs.
Ross
R A
RA
Department of Biological Sciences, Fordham University, Bronx, NY 10458.
Bossart
E
E
Spengler
B A
BA
Biedler
J L
JL
D001973:Bromodeoxyuridine / Q000494:pharmacology*; D003994:Bucladesine / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D005576:Colforsin / Q000494:pharmacology*; D003598:Cytoskeletal Proteins / Q000378:metabolism; D006801:Humans; D009447:Neuroblastoma / Q000473:pathology*; D018377:Neurotransmitter Agents / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology*
D003598:Cytoskeletal Proteins; D018377:Neurotransmitter Agents; D005576:Colforsin; D014212:Tretinoin; D003994:Bucladesine; D001973:Bromodeoxyuridine